Skip to main content
Premium Trial:

Request an Annual Quote

SurroMed Takes License to Ingenuity Pathway Analysis Application

NEW YORK, Dec. 8 (GenomeWeb News) - SurroMed said today that it has licenced Ingenuity Systems' Pathway Analysis, an application that maps relationships between proteins, genes, complexes, cells, tissues, drugs, and diseases.


Financial terms of the arrangement were not disclosed.


Ingenuity has recently licensed the Pathways Analysis system to the  Genomics Institute of the Novartis Research Foundation, the  Stanford Genome Technology Center, and  GlaxoSmithKline, and recently signed a software distribution  deal with investor Affymetrix.

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.